Douglas Lawrence
Directeur Général chez Hygieia, Inc.
Profil
Douglas Lawrence is currently the Chief Executive Officer at Hygieia, Inc. He was previously the Chief Executive Officer at CeQur SA. He holds a Master's in Business Administration from Kellogg School of Management and an undergraduate degree from The Jerome Fisher Program in Management & Technology.
Postes actifs de Douglas Lawrence
| Sociétés | Poste | Début |
|---|---|---|
Hygieia, Inc.
 Hygieia, Inc. Industrial MachineryProducer Manufacturing Hygieia, Inc. engages in the provision of healthcare services focusing on insulin management. It offers the d-Nav Insulin Management Program. The company was founded by Israel Hodish and Eran Bashan in 2008 and is headquartered in Livonia, MI. | Directeur Général | 23/08/2022 |
Anciens postes connus de Douglas Lawrence
| Sociétés | Poste | Fin |
|---|---|---|
CeQur SA
 CeQur SA Medical SpecialtiesHealth Technology CeQur SA develops medical devices for diabetes patients. It offers n insulin delivery device that provides three days of consistent, basal insulin deliver along with on-demand bolus insulin. The company was founded by James L. Peterson in January 2008 and is headquartered in Horw, Switzerland. | Directeur Général | - |
Formation de Douglas Lawrence
| Kellogg School of Management | Masters Business Admin |
| The Jerome Fisher Program In Management & Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Hygieia, Inc.
Hygieia, Inc. Industrial MachineryProducer Manufacturing Hygieia, Inc. engages in the provision of healthcare services focusing on insulin management. It offers the d-Nav Insulin Management Program. The company was founded by Israel Hodish and Eran Bashan in 2008 and is headquartered in Livonia, MI. | Producer Manufacturing |
CeQur SA
CeQur SA Medical SpecialtiesHealth Technology CeQur SA develops medical devices for diabetes patients. It offers n insulin delivery device that provides three days of consistent, basal insulin deliver along with on-demand bolus insulin. The company was founded by James L. Peterson in January 2008 and is headquartered in Horw, Switzerland. | Health Technology |
